Vivos Therapeutics Inc (NAS:VVOS)
$ 2.09 0.14 (7.18%) Market Cap: 6.75 Mil Enterprise Value: 5.56 Mil PE Ratio: 0 PB Ratio: 9.15 GF Score: 55/100

Q2 2021 Vivos Therapeutics Inc Earnings Call Transcript

Aug 12, 2021 / 09:00PM GMT
Release Date Price: $68.5 (-2.84%)
Operator

Good day, everyone, and welcome to the Vivos Therapeutics' Second Quarter 2021 Conference Call. (Operator Instructions) This conference call is being recorded, and a replay of today's call will be available on the Investor Relations section of Vivos' website and will remain posted there for the next 30 days.

I will now hand the call over to Mr. Edward Loew, Vivos' Investor Relations Officer, for introductions and the reading of the safe harbor statement. Please go ahead, sir.

Edward A. Loew
Vivos Therapeutics, Inc. - Chief Strategy Officer, Senior VP of Strategy & IR Officer

Thank you, operator. Hello, everyone, and welcome to Vivos Therapeutics' Second Quarter 2021 Earnings Conference Call. A copy of the company's earnings press release is available on the Investor Relations section of our website at www.vivoslife.com.

With us on today's call are Kirk Huntsman, Vivos' Chairman and Chief Executive Officer; and Brad Amman, Chief Financial Officer. Today, we'll review the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot